Go to the list of all blogs
John Y White's Avatar
published in Blogs
Aug 05, 2026
Galaxy Digital Holdings (GLXY) Falls -12.8% in 30 Days Amid Debt Financing and Crypto Market Pressure

Galaxy Digital Holdings (GLXY) Falls -12.8% in 30 Days Amid Debt Financing and Crypto Market Pressure

Key Takeaways

  • Galaxy Digital Holdings (GLXY) declined approximately 12.8% over the past 30 days, falling from a close of $25.40 on July 6, 2026, to $22.14 as of August 4, 2026.
  • A $3.507 billion senior secured notes offering to fund the Helios Phase II data center expansion triggered significant leverage concerns among investors.
  • Broader cryptocurrency market weakness and a stronger U.S. dollar pressured digital asset-related stocks across the board.
  • Competitive fears intensified after Meta Platforms was reported to be building its own AI cloud operation, raising questions about CoreWeave's positioning as Galaxy's anchor data center tenant.
  • The stock experienced extreme single-session volatility, including a 12.8% intraday crash on July 29 followed by a 17.9% rebound the next day.
  • Despite the selloff, Wall Street maintains a consensus Moderate Buy rating with an average price target near $39, suggesting significant potential upside from current levels.

Galaxy Digital Holdings (GLXY) Business Overview and Strategic Position

Galaxy Digital Holdings Ltd., founded by former hedge fund manager Michael Novogratz, is a diversified financial services and investment management firm focused on the digital asset and blockchain technology ecosystem. The company operates across multiple business lines: institutional trading and market-making for digital tokens, asset management catering to institutional and high-net-worth clients, principal investing in blockchain-related ventures, and investment banking advisory services. In recent years, Galaxy has made a decisive strategic pivot into physical infrastructure, developing the Helios data center campus in Dickens County, Texas, which provides high-performance computing capacity for artificial intelligence workloads. The company's anchor tenant at Helios is CoreWeave, an AI-focused cloud provider backed by Nvidia, under a 15-year lease agreement covering 800 megawatts of gross power capacity. This dual exposure to both cryptocurrency markets and the AI infrastructure buildout makes GLXY a unique hybrid play that attracts both digital-asset and tech-infrastructure investors. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Galaxy Digital Holdings (GLXY) Stock Price Performance Over the Past 30 Days and Quarter

Over the past 30 days, GLXY declined from a closing price of $25.40 on July 6, 2026, to $22.14 on August 4, 2026, representing a drop of approximately 12.8%. The stock's path was far from linear: shares traded as high as $25.41 on July 21 before a pronounced selloff accelerated in the final two weeks of the period, culminating in a sharp plunge to an intra-month low of $18.22 on July 29. A vigorous two-day recovery lifted the stock back above $21.50, but sentiment remained fragile through early August.

The quarterly picture is even starker. From mid-May levels above $31 to the current price near $22, GLXY has shed roughly 28–30% of its value over approximately three months. The stock entered the quarter benefiting from optimism around the Helios Phase I completion and the CoreWeave lease, but a combination of crypto market headwinds, aggressive debt financing, and competitive concerns in the AI cloud space steadily eroded those gains. The 50-day moving average has declined to approximately $28.75, well above the current trading range, underscoring the sustained downward pressure.

Factors Driving GLXY Stock Moves in the Last 30 Days

The most consequential catalyst during the past 30 days was Galaxy's announcement on July 23 that its subsidiary Galaxy Helios Data Centers II LLC had priced a $3.507 billion private offering of 9.875% senior secured notes due 2031. While the proceeds are earmarked to finance the development of two new buildings with 400 MW of utility capacity and 260 MW of critical IT capacity, the high-yield nature of the debt—priced at roughly 9%—signaled speculative-grade risk to fixed-income markets and raised concerns about balance sheet leverage. Galaxy's existing debt-to-equity ratio already stood at elevated levels compared to peers, and the new issuance meaningfully amplifies financial risk. From what I see, this financing step shifted investor focus toward leverage metrics.

Simultaneously, the stock faced pressure from broader cryptocurrency market dynamics. A strengthening U.S. dollar and declining Bitcoin prices weighed on the entire digital asset sector, triggering correlated selling across crypto-exposed equities. A report on July 1 that Meta Platforms was developing its own AI cloud offering for external customers introduced a competitive overhang, as investors reassessed CoreWeave's long-term demand trajectory. CoreWeave shares fell roughly 14% on the day of the Meta report, and Galaxy—given its heavy reliance on CoreWeave as its anchor Helios tenant—was swept up in the selloff. Rosenblatt Securities analyst Chris Brendler subsequently called the reaction "overdone," maintaining that the Meta development did not signal deteriorating contracted demand, but the damage to short-term sentiment was done. I checked this development against broader sector data using Tickeron’s AI Trend Prediction Engine to gauge the potential impact.

Additionally, Piper Sandler lowered its price target on GLXY from $36 to $33 on July 17, citing a more cautious outlook, while maintaining an Overweight rating. Insider selling activity, including a director selling 250,000 shares earlier in the quarter and cumulative insider sales exceeding $15.7 million, further dampened retail and institutional confidence.

Drivers Behind GLXY Performance Over the Last Quarter

The quarterly decline reflects a confluence of structural and sentiment-driven factors. From a macro perspective, the Federal Reserve's monetary policy stance and a risk-off tilt in global markets have disproportionately affected high-beta names like Galaxy Digital, which carries a beta near 4.8. The stock's sensitivity to both crypto asset prices and speculative-growth narratives has made it particularly vulnerable to sector rotation away from risk assets.

On the operational side, while Galaxy completed Phase I of its Helios data center campus on schedule and began delivering 133 MW of critical IT load to CoreWeave, the market's focus shifted from execution milestones to financing sustainability. The $3.507 billion debt raise, though necessary for Phase II expansion, transformed the investment narrative from pure growth to a leverage story. Investors also digested mixed Q1 2026 results: revenue of $10.04 billion represented a decline from the prior-year period, and the company posted a net loss of $216.3 million, though operating income turned positive year-over-year. The path forward hinges on Galaxy's ability to convert its AI infrastructure assets into predictable, recurring cash flows capable of servicing its growing debt load, all while navigating persistent crypto market volatility.

Key Factors to Monitor for GLXY Going Forward

Looking ahead, the most critical factor for GLXY will be the successful closing and deployment of the $3.507 billion notes offering, expected by late July, and subsequent construction progress on Helios Phase II. Any delays, cost overruns, or tenant-related issues with CoreWeave could materially shift the risk-reward calculus. Investors should also monitor quarterly earnings for signs of improving operating margins and narrowing net losses, as the company is expected to move toward profitability in the coming fiscal year. Broader cryptocurrency market trends—particularly Bitcoin price direction and ETF flow data—will continue to influence sentiment given Galaxy's trading and principal investment exposure. Additionally, competitive dynamics in the AI cloud infrastructure space, including capacity announcements from hyperscalers such as MSFT, AMZN, and GOOGL, deserve close attention. Regulatory developments around digital asset custody, staking, and tokenization could also serve as either tailwinds or headwinds depending on the policy trajectory in Washington. One thing that stands out is how these elements could influence the stock's recovery path.

Navigating Volatility with AI-Driven Tools

In volatile market environments like the one currently facing GLXY, I often look to systematic approaches for discipline. Tickeron’s AI Trading Bots offer a range of strategies across different timeframes, with performance metrics that help evaluate suitability before use. In my view, reviewing these tools has been useful for identifying consistent methods amid rapid price swings in crypto and tech-related names.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GLXY

GLXY's RSI Indicator ascending out of oversold territory

The RSI Oscillator for GLXY moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 3 similar instances when the indicator left oversold territory. In of the 3 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 12 cases where GLXY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GLXY just turned positive on August 04, 2026. Looking at past instances where GLXY's MACD turned positive, the stock continued to rise in of 7 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GLXY advanced for three days, in of 73 cases, the price rose further within the following month. The odds of a continued upward trend are .

GLXY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLXY as a result. In of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for GLXY crossed bearishly below the 50-day moving average on July 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLXY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GLXY entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GLXY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.340) is normal, around the industry mean (4.600). P/E Ratio (47.250) is within average values for comparable stocks, (48.459). GLXY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (0.166) is also within normal values, averaging (31.834).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLXY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.4B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 5%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -12%. SONM experienced the highest price growth at 35%, while TOP experienced the biggest fall at -80%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was -43% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 69
Price Growth Rating: 61
SMR Rating: 76
Profit Risk Rating: 85
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
GLXY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Profile
Details
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.